Flugen, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.flugen.com
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults
- Conditions
- Influenza Vaccine
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- FluGen Inc
- Target Recruit Count
- 303
- Registration Number
- NCT05163847
- Locations
- 🇺🇸
United Medical Research, Port Orange, Florida, United States
🇺🇸Velocity Clinical Research, Cedar Park, Texas, United States
🇺🇸Johnson County Clin Trials, Lenexa, Kansas, United States
Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old
- Conditions
- Influenza Vaccine
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- FluGen Inc
- Target Recruit Count
- 122
- Registration Number
- NCT04785794
- Locations
- 🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸Accel Clinical, DeLand, Florida, United States
🇺🇸Johnson County Clin Trials, Lenexa, Kansas, United States
Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines
- Conditions
- Influenza A
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- FluGen Inc
- Target Recruit Count
- 206
- Registration Number
- NCT03999554
- Locations
- 🇺🇸
RCA, Hollywood, Florida, United States
🇺🇸JCCT, Lenexa, Kansas, United States
🇺🇸AMR Lexington, Lexington, Kentucky, United States
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers
- Conditions
- Flu
- First Posted Date
- 2016-07-04
- Last Posted Date
- 2020-08-10
- Lead Sponsor
- FluGen Inc
- Target Recruit Count
- 96
- Registration Number
- NCT02822105
- Locations
- 🇺🇸
JCCT, Lenexa, Kansas, United States
Intracutaneous Delivery of Varied Dose Volumes of Saline
- Conditions
- Influenza
- First Posted Date
- 2013-01-14
- Last Posted Date
- 2017-08-02
- Lead Sponsor
- FluGen Inc
- Target Recruit Count
- 24
- Registration Number
- NCT01767337
- Locations
- 🇺🇸
Accelovance Inc, Melbourne, Florida, United States
- Prev
- 1
- 2
- Next